AnalystsNathan TreybeckNathan Treybeck's Stock Forecasts
AnalystsNathan Treybeck
Sectors:
Analyst Ranking
Bottom 9%
#4895 out of 5334 analysts
Average Return
-9.09%
Win Rate
26%5 out of 19
Risk vs Reward
Poor
Good
Nathan Treybeck's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Procept Biorobotics CorpPRCT | +121.48% | $40.55 | $89.81 | 2023-12-13 - 2024-12-12 | Strong Buy |
Procept Biorobotics CorpPRCT | +77.90% | $48.60 | $86.46 | 2024-01-09 - 2025-01-08 | Strong Buy |
Procept Biorobotics CorpPRCT | +38.88% | $33.90 | $47.08 | 2023-01-12 - 2024-01-11 | Strong Buy |
Nevro CorpNVRO | +11.80% | $4.83 | $4.26 | 2024-08-07 - 2024-12-03 | Strong Sell |
Irhythm Holdings IncIRTC | +9.67% | $108.72 | $119.23 | 2023-02-07 - 2024-02-06 | Strong Buy |
Nathan Treybeck Analyst Color
Get additional color on Nathan Treybeck's coverage of popular stocks
Nathan Treybeck's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Resmed IncRMD | 4 | Hold | $225.00 | +15.23% | Maintains | 17 days ago |
Lemaitre Vascular IncLMAT | 4 | Hold | $104.00 | +8.80% | Maintains | 3 months ago |
Irhythm Holdings IncIRTC | 8 | Strong Buy | $180.00 | +64.84% | Maintains | 3 months ago |
Procept Biorobotics CorpPRCT | 10 | Strong Buy | $34.00 | +103.71% | Maintains | 5 months ago |
Integer Holdings CorpITGR | 5 | Hold | $84.00 | -14.82% | Maintains | 5 months ago |
Nevro CorpNVRO | 4 | Hold | $4.00 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.